Insider · CIK 0001214505
Geoffrey Nichol
Files at TPST (Tempest Therapeutics, Inc.). First filing -, latest -.
In brief
Geoffrey Nichol files SEC Form 4 as director at TPST (Tempest Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Geoffrey Nichol has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | TPST Tempest Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,230 | $0.00 | $0 | 1,230 | Jan 28, 2026 |
Questions about Geoffrey Nichol
Answered from the filings on this page, as of the latest one.
Is Geoffrey Nichol buying or selling?
Geoffrey Nichol has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Geoffrey Nichol's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Geoffrey Nichol has 0.
Where does Geoffrey Nichol file Form 4?
Geoffrey Nichol has filed Form 4 at TPST (Tempest Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.